Prof. Dal-Hee Min

E-mail : dalheemin@snu.ac.kr

Phone : +82-2-880-4338

Dept of chemistry, building 503, Room 424, Seoul National University, Korea

Research interests : Nanotechnology / Biosensor / Drug Delivery / Chemical Biology

Career

2011–present Professor, Chemistry, Seoul National University

2017–2019 Editorial Advisory Board, Analytical Chemistry, American Chemical Society (USA)

2013–2019 Associate Editor, Journal of Materials Chemistry B, Royal Society of Chemistry (UK)

2013–2019 Editorial Board Member, 2D Materials, Institute of Physics (IOP, UK)

2014–present Chief Technology Officer (CTO), Co-Founder, Lemonex, Inc.

2007–2011 Professor, Chemistry, KAIST

2005–2007 Postdoctoral Researcher, Bioengineering, MIT

Awards & Academic Activities

2019 Order of Science and Technology Merit, Doyak Medal (Ministry of Science and ICT, Korea)

2015 BRIC Top 5's Applied Research Accomplishment (BRIC, Korea)

2014 Korea L’Oreal UNESCO Fellowship Award for Women in Science (L’Oreal, UNESCO)

2013 Distinguished Lectureship Award (Chemical Society of Japan, Japan)

2012 KCS-Wiley Young Chemist Award (KCS-Wiley, Korea)

2011 Top 100 Excellent Research Accomplishment Award (National Science & Technology Commission, Korea)

2010 Outstanding Teaching Award–Introduction to Chemical Biology (Department of Chemistry, KAIST, Korea)

2010 The Ewon Professorship (KAIST, Korea)

Education

2000–2005 Ph.D. Chemistry, The University of Chicago, Advisor: Prof. Milan Mrksich

1997–1999 M.S. Chemistry, Seoul National University

1993–1997 B.S. Chemistry, Seoul National University

Selected Publications

1. "Development of a cancer nanovaccine to induce antigen-specific immune responses based on large-sized porous silica nanoparticles" ACS Appl. Mater. Interfaces (2023)

2. "Multifunctional synthetic nano-chaperone for peptide folding and intracellular delivery", Nature Communications (2022)

3. "Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing", Journal of Controlled Release (2022)

4. "Nanoparticle delivery of recombinant IL-2 (BALLkine-2) achieves durable tumor control with less systemic adverse effects in cancer immunotherapy", Biomaterials (2022)

5. "3D Microfluidic platform and tumor vascular mapping for evaluating anti-angiogenic RNAi-based nanomedicine", ACS Nano (2020)

6. "Direct monitoring of cancer-associated mRNAs in living cells to evaluate the therapeutic RNAi efficiency using fluorescent nanosensor", ACS Sensors (2019)

7. "Recent advances in RNA therapeutics and RNA delivery systems based on nanoparticles", Adv. Therap. (2018)

8. "Development of dual-pore coexisting branched silica nanoparticles for efficient gene-chemo cancer therapy", Small (2018)

9. "Biosensors based on graphene oxide and its biomedical application" Adv. Drug Deliv. Rev. (2016)

10. "Direct cellular delivery of human proteasomes to delay tau aggregation", Nature Communications (2014)